Priya Kumthekar
Alliance for Clinical Trials in Oncology · Northwestern University Medical Center · Northwestern University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Priya Kumthekar as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:59 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07605364 · Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain CancerAlliance for Clinical Trials in Oncology · not yet recruiting · Advanced Glioblastoma · study chair
- N/ANCT05414123 · A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSideBiocept, Inc. · terminated · Leptomeningeal Metastasis, Leptomeningeal Disease, Leptomeningeal Neoplasms · principal investigator
- Early Ph1NCT03020017 · NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing SurgeryNorthwestern University · completed · Gliosarcoma, Recurrent Glioblastoma · principal investigator
- Ph2NCT02847559 · Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 MeningiomaNorthwestern University · completed · Anaplastic (Malignant) Meningioma, Atypical Meningioma, Grade II Meningioma · principal investigator
- Ph2NCT02047214 · Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin TherapyCortice Biosciences, Inc. · terminated · Glioblastoma Multiforme · principal investigator
- Ph2NCT01898130 · Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation TherapyNorthwestern University · completed · Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific · principal investigator
- Ph2NCT01125046 · Bevacizumab in Treating Patients With Recurrent or Progressive MeningiomasNorthwestern University · completed · Acoustic Schwannoma, Adult Anaplastic Meningioma, Adult Ependymoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and RadiationR01CA272639 · NCI · NORTHWESTERN UNIVERSITY · fiscal years 2023 to 2026 · $497,895 awarded in 2026Same name and institution; not confirmed by an ID
- Clinical Protocol and Data ManagementP30CA060553 · NCI · NORTHWESTERN UNIVERSITY · fiscal years 2021 · $490,918 awarded in 2021Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name in glioblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 11:59 UTC. The ranking covers the 200 most relevant of 13 PubMed records, and a shared surname and initials can bring in a namesake. All 13 on PubMed
- A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.Sci Transl Med · 2021276 citationsRCR 17.1
- Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.Nat Med · 2023275 citationsRCR 24.2
- 220 citationsRCR 23.5
- Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial.Lancet Oncol · 2021183 citationsRCR 10.0
- Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.Cancer Chemother Pharmacol · 2017113 citationsRCR 3.8
- Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.Neuro Oncol · 201797 citationsRCR 3.0
- 97 citationsRCR 3.7
- Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma.Neuro Oncol · 201867 citationsRCR 2.2
- Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial.JAMA Oncol · 202434 citationsRCR 3.6
- Dynamic release of extracellular particles after opening of the blood-brain barrier predicts glioblastoma susceptibility to paclitaxel.Nat Commun · 20258 citationsRCR 2.1